Since its discovery in the 1990s, "programmed cell death protein 1," or PD-1, has been regarded as a leading target in cancer treatments.

Much of our knowledge of the protein PD-1, a leading cancer treatment target, comes from studies in mice. In a comprehensive assessment of PD-1, researchers have found that PD-1 in mice is ...

Scientists have discovered significant discrepancies in PD-1 between humans and rodents, indicating that common lab models ...

Following a recent trial, doctors at the Christie Hospital are optimistic about the study of HMBD-001 in the treatment of bladder cancer.

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

Immuno-oncology (IO) drugs or cancer therapeutics represent one of the most promising areas of medical innovation in the next ...

While frequent U.S. flyers may recognize optional face-scanning tech like TSA-approved Clear, Russia just rolled out a system ...

HIF1α identified as key regulator that induces cancer-killing ability of hypoxic T cells, playing a role in ICB resistance.

Check Point Software Technologies Ltd. (NASDAQ:CHKP – Get Free Report) was the recipient of a significant decrease in short interest during the month of December. As of December 15th, there was short ...

Check Point (CHKP – Research Report) received a Hold rating and a $207.00 price target from Goldman Sachs analyst Gabriela Borges yesterday.

India had been a net importer of mobile phones since 2000, yet its net import bill in the category had stayed stable at ...

In a groundbreaking Interview, Professor Raz Yirmiya discusses his innovative research at the intersection of inflammation ...